Epinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s.

The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987. The global epinephrine autoinjector market is growing at a steady rate and is projected to grow at a CAGR of 14.58%, during the forecast period.The market which is still in its nascent stage in APAC provides many penetration

opportunities for the global vendors.

PART 01: Executive summary 6

PART 02: Scope of the report 19

Market overview 19

Top-vendor offerings 20

PART 03: Market research methodology 21

Research methodology 21

Economic indicators 21

PART 04: Introduction 22

Key market highlights 22

Epinephrine autoinjector: Overview 25

PART 05: Market landscape 28

Market overview 28

Market size and forecast 30

Five forces analysis 32

PART 06: Market segmentation by dosage 33

Global epinephrine autoinjector market by 0.15gm

dosage 35

Global epinephrine autoinjector market by 0.30gm

dosage 36

Global epinephrine autoinjector market by 0.5gm

dosage 37

PART 07: Market segmentation by age group 39

PART 08: Market segmentation by end-user 40

Hospitals and clinics 40

Individuals 41

PART 09: Geographical segmentation 42

Epinephrine autoinjector market in the Americas 43

Epinephrine autoinjector market in EMEA 47

Epinephrine autoinjector market in APAC 49

PART 10: Market drivers 52

Increasing prevalence of allergies 52

Technological advances 53

Marketing strategies 54

PART 11: Impact of drivers 56

PART 12: Market challenges 57

Product recalls and regulatory issues 57

Presence of substitutes 58

High cost 59

PART 13: Impact of drivers and challenges 60

PART 14: Market trends 61

Tentative product launches 61

Growing awareness about epinephrine autoinjectors 62

Patient assistance programs 63

PART 15: Vendor landscape 64

Competitive scenario 64

Key news 67

Geographical presence of key vendors 68

PART 16: Key vendor analysis 69

ALK-Abelló 69

Impax Laboratories 72

Lincoln Medical 75

Mylan 78

Other prominent vendors 81

PART 17: Appendix 82

List of abbreviations 82

PART 18: Explore Technavio 83